AVGO
45
3
D
46
3
AIZ
76
-2
AVY
50
3
CA
36
12
DUK
55
-2
DG
72
4
BF.B
33
-2
BDX
61
2
CNP
57
3
AAL
48
-2
BK
72
-2
AN
50
-2
CAT
69
11
DOV
71
10
AMT
30
4
CVX
29
-2
CHRW
76
-3
CNX
38
-3
CMA
67
2
AVGO
45
3
D
46
3
AIZ
76
-2
AVY
50
3
CA
36
12
DUK
55
-2
DG
72
4
BF.B
33
-2
BDX
61
2
CNP
57
3
AAL
48
-2
BK
72
-2
AN
50
-2
CAT
69
11
DOV
71
10
AMT
30
4
CVX
29
-2
CHRW
76
-3
CNX
38
-3
CMA
67
2
Financhill
Back

Enliven Therapeutics, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
21

ELVN
Enliven Therapeutics, Inc.

Last Price:
$16.27
Seasonality Move:
-8.68%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
21
Enliven Therapeutics, Inc. (ELVN) is a Sell

Is Enliven Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Enliven Therapeutics, Inc. [ELVN] share price is $16.30. The Score for ELVN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • ELVN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $39.6400. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ELVN Stock Price Chart

What is Enliven Therapeutics, Inc.'s stock price today?

  • The Enliven Therapeutics, Inc. share price today is $16.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ELVN is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $39.6400
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.

ELVN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.14 Sell
Relative Strength Index (14 RSI): 37.38 Sell
Chaikin Money Flow: 6155 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.1 - 21.4) Sell
Bollinger Bands (100): (18.36 - 21.52) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.28 Buy
Relative Strength Index (14 RSI): 66.31 Buy
Chaikin Money Flow: -583105 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.9202 - 36.9202) Buy
Bollinger Bands (100): (20.9405 - 34.5405) Buy

ELVN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.75 Sell
20-day SMA: 18.66 Sell
50-day SMA: 20.07 Sell
200-day SMA: 19.82 Sell
8-day EMA: 17.01 Sell
20-day EMA: 18.2 Sell
50-day EMA: 19.38 Sell
200-day EMA: 20.22 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.31 Buy
20-day SMA: 35.4 Buy
50-day SMA: 33.69 Buy
200-day SMA: 22.3 Buy
8-day EMA: 30.99 Buy
20-day EMA: 18.54 Buy
50-day EMA: 8.93 Buy
200-day EMA: 2.46 Buy

Enliven Therapeutics, Inc. Earnings Growth & ELVN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.32 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Enliven Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):